Vaccins de peptide avec Seq ID No: 379 or 376 pour cancers exprimant des antigènes associés aux tumeurs

• 收藏
• 分享

专利权人:

Oncotherapy Science; Inc.

发明人:

申请号：

EP12175481.6

公开号：

EP2570428A3

申请日:

2008.02.21

申请国别(地区):

EP

年份:

2013

代理人:

摘要：

The present invention provides peptides having an amino acid sequence as set forth in SEQ ID NO: 376 or 379 as well as peptides having the above-mentioned amino acid sequences in which 1, 2, or several (e.g., up to 5) amino acids are substituted, deleted, or added, provided the peptides possess cytotoxic T cell inducibility. The present invention also provides drugs for treating or preventing a disease associated with over-expression of the CDH3, EPHA4, ECT2, HIG2, INHBB, KIF20A, KNTC2, TTK and/or URLC10, e.g. cancers containing as an active ingredient one or more of these peptides. The peptides of the present invention find further utility as vaccines.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/